Back to dashboard Episode 166

DIP Episode 166 - USMLE Step 2CK Rapid Review Series 20 (Psych)

PsychiatryMedium4 - HighHas Q&A

Step 2Step 3PsychiatryUSMLEStep 2Step 3

Topic

Bipolar Disorder diagnosis and management; Lithium toxicity (Nephrogenic DIADH)...

Key Takeaway

Lithium is the drug of choice for treating Bipolar Disorder due to its anti-suicidal properties, but clinicians must monitor for nephrogenic diabetes insipidus and avoid thiazide diuretics when managing volume depletion or DIADH associated with lithium use.

Runtime: 23.7 min

Published: 2019-10-09

Completed audio: Yes

Completed notes: Yes

Anki made: Yes

Section: RAPID REVIEW SERIES

Open Notion notes Episode source

Episode Notes

Source / episode info

Episode: 166
Title: Divine Intervention Episode 166 – USMLE Step 2 CK Rapid Review Series 20 (Psych).
Published: 2019-10-09
Source: Episode page

One-liner

This episode reviews high-yield psychopharmacology concepts, focusing on the diagnosis of Bipolar Disorder (manic/depressive episodes), the unique toxicities and management of Lithium (especially nephrogenic DIADH), and common side effects associated with SSR Is and SNR Is.

High-yield summary

Bipolar Diagnosis: Requires at least one manic episode (or hypomanic, depending on severity) AND a depressive episode for full diagnosis; however, the presence of a clear manic episode alone can meet criteria if symptoms persist >1 week (unless social dysfunction/hospitalization is required).
Lithium Toxicity & DIADH: Lithium causes nephrogenic diabetes insipidus by interfering with the inositol channel in the collecting duct principal cells. Treatment requires K+-sparing diuretics (Amiloride or Triamterene) and avoiding thiazides (like HCTZ) because volume depletion increases RAAS activity, worsening lithium reabsorption.
Acute Mania Management: When a patient is acutely manic, the initial treatment involves an anti-psychotic agent, with Lithium added concurrently for long-term maintenance therapy.
SSRI/SNRI Side Effects: SSR Is are associated with sexual dysfunction (low libido) and can be used to treat Premenstrual Dysphoric Disorder (PMDD) or premature ejaculation by exploiting this side effect. SNR Is (e.g., Venlafaxine) carry a risk of hypertension.
MDD Criteria: Diagnosis requires 5 out of 9 CIGI-CAP symptoms for at least two weeks, with the absence of a major depressive episode preceding the onset of mania/hypomania to rule out Bipolar Disorder.

Learning objectives

Differentiate the diagnostic criteria for Major Depressive Disorder (MDD) versus Bipolar Disorder.
Identify the drug class and mechanism responsible for lithium's anti-suicidal properties.
Recognize the signs, symptoms, and underlying pathophysiology of nephrogenic diabetes insipidus associated with lithium use.
Select appropriate agents to treat lithium-induced DIADH while avoiding those that exacerbate RAAS activity (e.g., thiazides).
Correlate common psychotropic drug side effects (e.g., SSRI sexual dysfunction, SNRI hypertension) with clinical management strategies.

Board exam buzzwords

Condition	Key Finding	Association	Board Exam Tip
Bipolar Disorder	Manic/Depressive Episodes	Lithium; Anti-psychotics	Remember that the anti-suicidal properties of lithium are a high-yield fact.
Nephrogenic DIADH	Polyuria, Polydipsia, Hypernatremia	Lithium; Inositol channel blockade (E NaC)	Always think K+-sparing diuretics (Amiloride/Triamterene) when treating this complication.
SSR Is	Sexual Dysfunction (Low Libido)	Serotonin reuptake inhibition	This side effect can be exploited therapeutically (e.g., for PMDD or premature ejaculation).
SNRI (Venlafaxine)	Hypertension	Increased sympathetic tone/NE effects	If a psych drug causes hypertension, suspect an SNRI class agent.

Rapid review table

Topic	Key Point	Context	Exam Relevance
Bipolar Dx	Manic episode + Depressive episode (or just Mania)	Diagnosis requires symptoms for >1 week; exception applies if social dysfunction/hospitalization is needed.	Distinguishing Bipolar Disorder from MDD based on symptom history and duration.
Lithium Toxicity	Nephrogenic DIADH	Lithium interferes with the inositol channel in collecting duct principal cells.	Critical management point: Avoid thiazides (HCTZ) due to RAAS activation risk.
MDD Criteria	5 out of 9 CIGI-CAP symptoms for 2 weeks	Must rule out mania/hypomania; symptom onset must be recent and not related to life stress.	Trap question: Do not confuse the required number of symptoms or duration.
Acute Mania Tx	Anti-psychotic + Lithium (for maintenance)	Initial stabilization requires an antipsychotic, followed by lithium for long-term mood stability.	Knowing that acute management differs from chronic maintenance therapy is key.

Board-speak -> diagnosis

Board-speak / Vignette phrase	Diagnosis / Concept	Why it fits
A patient presents with grandiosity, decreased need for sleep, and flight of ideas over 10 days.	Manic Episode (Bipolar Dx)	These are classic signs of mania; the duration (>7 days) confirms the severity required for diagnosis.
A woman taking lithium develops polyuria and polydipsia refractory to vasopressin, accompanied by hypernatremia.	Nephrogenic Diabetes Insipidus (DIADH)	Lithium interferes with ADH action in the collecting duct principal cells, leading to impaired water reabsorption.
A patient on lithium presents with volume depletion and worsening DIADH. The physician should add which drug?	Amiloride or Triamterene (K+-sparing diuretics)	These agents block the epithelial sodium channel (E NaC), counteracting the RAAS-mediated increase in lithium reabsorption, unlike thiazides.
A patient with Bipolar Disorder is acutely manic and requires immediate stabilization. The initial treatment should be:	Anti-psychotic agent + Lithium	An anti-psychotic addresses acute symptoms; Lithium is added for long-term mood stabilization/maintenance therapy.
A young man presents to the clinic complaining of low libido and difficulty achieving orgasm after starting an SSRI for GAD.	Sexual Dysfunction (SSRI side effect)	This is a common, expected adverse effect of SSR Is due to serotonin receptor activity in sexual pathways.
A patient with suspected Bipolar Disorder has been stable on lithium but develops symptoms suggestive of hypothyroidism.	Lithium-induced Hypothyroidism	Lithium frequently causes thyroid dysfunction and requires baseline TSH monitoring; treatment may involve levothyroxine.

Differential diagnosis / distinguishing features

Nephrogenic DIADH vs Primary Polydipsia

Key Features	Distinguishing Findings	Next Step
Nephrogenic DIADH: Kidney failure to respond to ADH (vasopressin).	Primary Polydipsia: Excessive fluid intake leading to dilution/overhydration.	Measure urine osmolality and serum sodium; if high Uosm despite low plasma osmolality, consider nephrogenic cause.

SSRI vs SNRI side effects

Key Features	Distinguishing Findings	Next Step
SSRI: Primarily inhibits Serotonin reuptake (e.g., Fluoxetine).	SNRI: Inhibits both Serotonin and Norepinephrine reuptake (e.g., Venlafaxine).	If hypertension is suspected, consider switching from an SSRI to a tricyclic or vice versa; suspect SNR Is first.

Management pearls

Lithium Monitoring: Always obtain baseline TSH before initiating lithium therapy due to the risk of hypothyroidism.
Acute Mania Stabilization: For acute mania, initiate treatment with an anti-psychotic agent and start lithium concurrently for long-term mood stabilization; do not wait for symptoms to resolve naturally.
Treating Lithium-Induced DIADH: Use K+-sparing diuretics (Amiloride or Triamterene) because they block the E NaC channel, which is independent of RAAS activity and does not worsen lithium reabsorption.
PMDD Treatment: SSR Is are first-line agents for PMDD; these drugs can also be used to treat generalized anxiety disorder (GAD).

Don't miss

🚨

Lithium's anti-suicidal properties: It is one of only two psychotropics (the other being Clozapine) proven to reduce suicide risk.

🚨

HCTZ/Thiazides: Never use thiazide diuretics in a patient with suspected lithium toxicity or nephrogenic DIADH, as they increase RAAS activity and worsen lithium retention.

🚨

CIGI-CAP Acronym: Remember the 5 out of 9 symptoms (Sleep loss, Loss of interest, Guilt, Energy decrease, Poor concentration, Appetite issues, Psychomotor retardation, Suicidal ideation).

Integration & clinical reasoning

Psychiatry & Endocrine System: Lithium toxicity provides a classic example of drug interaction with renal physiology. The mechanism involves the interference with the inositol channel (E NaC) in the collecting duct principal cells, linking psychopharmacology to nephrology.
SSRI/SNRI and Sexual Health: The common side effect of sexual dysfunction can be therapeutically leveraged for conditions like premature ejaculation or PMDD, demonstrating a functional understanding of drug mechanisms beyond just adverse effects.

Concept connections / cross-references

For detailed review on the endocrine system and renal physiology (e.g., RAAS, ADH), see Episode 137 .
For general psychopharmacology principles, refer to [ Episode 165 ].

High-yield association table

Condition	Association	Mechanism	Clinical Significance
Bipolar Disorder	Lithium	Mood stabilizer; decreases suicide risk	Cornerstone of chronic psychiatric management; requires careful monitoring for toxicity.
Nephrogenic DIADH	Amiloride/Triamterene	Blocks E NaC channel in collecting duct principal cells	Used to treat lithium-induced polyuria without exacerbating RAAS activity.
SSR Is	Sexual Dysfunction (Low Libido)	Serotonin reuptake inhibition	Can be used therapeutically for PMDD or premature ejaculation by exploiting the side effect.
SNRI (Venlafaxine)	Hypertension	Increased sympathetic tone/NE effects	Requires monitoring of blood pressure; often a differential diagnosis when hypertension is suspected in psych patients.

Key terms glossary

Term	Definition	Context	Example
Manic Episode	Distinct period of abnormally and persistently elevated, expansive, or irritable mood AND increased activity/energy lasting 1 week.	Bipolar Disorder diagnosis.	Grandiosity, decreased need for sleep, flight of ideas.
Nephrogenic DIADH	Kidney inability to respond to ADH (vasopressin), leading to excessive free water loss.	Lithium toxicity; collecting duct principal cell dysfunction.	Polyuria and hypernatremia in a patient taking lithium.
CIGI-CAP	Acronym for 9 symptoms of MDD: Sleep, Loss of interest, Guilt, Energy decrease, Poor concentration, Appetite issues, Psychomotor retardation, Suicidal ideation.	Major Depressive Disorder diagnosis.	Requires 5 symptoms present for 2 weeks.
K+-Sparing Diuretics	Thiazides that block the E NaC channel (e.g., Amiloride).	Treatment of DIADH associated with lithium use.	Used instead of HCTZ when managing lithium-induced polyuria.

Study optimization

Topic	Study Approach	Priority	Resources
Bipolar Disorder	Master the diagnostic criteria and acute vs. chronic management strategies.	High	Review flowcharts for mania/depression; memorize drug classes (mood stabilizers).
Lithium Toxicity	Focus on mechanism of DIADH and contraindicated drugs.	Critical	Use mnemonics: "L-DIADH -> Avoid Thiazides, Use Amiloride."
Psychopharmacology Side Effects	Create association tables linking drug class/drug to common side effect (e.g., SSRI -> Sexual Dysfunction).	Medium-High	Practice vignettes that present a symptom and ask for the most likely causative drug class.

Question pattern recognition

Diagnosis Pattern: Recognizing which constellation of symptoms defines a specific mood disorder (Bipolar vs MDD).
Toxicology/Mechanism Pattern: Understanding how a drug interferes with a physiological process (Lithium -> E NaC channel blockade in collecting duct).
Management Algorithm Pattern: Knowing the sequence of care for acute crises (e.g., Acute Mania: Antipsychotic first, then Lithium added).

Test yourself

Common mistakes to avoid

🚫

Mistake 1: Confusing Bipolar and MDD Dx. Assuming that the presence of depressive symptoms automatically means Bipolar Disorder. Correction: Always screen for a history of mania/hypomania first.

🚫

Mistake 2: Using Thiazides in DIADH. Thinking HCTZ is appropriate for polyuria. Correction: Thiazides increase RAAS activity, worsening lithium retention and toxicity; use K+-sparing diuretics instead.

🚫

Mistake 3: Misunderstanding the "One Week Rule." Assuming that if a person has manic symptoms for only 6 days, it cannot be Bipolar Disorder. Correction: The one-week rule is waived if there is significant social dysfunction or hospitalization required.

Common traps

⚠️

Trap 1 (Lithium): Being asked to treat DIADH with an agent that increases RAAS activity (e.g., HCTZ). Remember: K+-sparing diuretics are the answer.

⚠️

Trap 2 (Bipolar Dx): Presenting a patient who has only had depressive symptoms but also mentions past periods of "feeling great" or "high energy." Always ask about elevated mood states to rule out Bipolar Disorder.

⚠️

Trap 3 (SSRI/SNRI): Assuming that sexual dysfunction is only an adverse effect. Remember it can be therapeutically exploited for PMDD or premature ejaculation.

Original transcript with highlights

Okay, welcome. My name is Divine. This is episode 166 of the Divine Intervention Podcast. And this is in this episode, we continue the Rapid Review series for the USMLS Step 2 CK exam. And this one is going to be focused on psychiatry. I don't know for whatever reason, Psych is now becoming quite relevant. Let me just put it that way for a work of a better term. It's becoming quite relevant on the USMLS exams. So that's something you absolutely want to become a monster at. Especially like the psych drugs. But I'm going to talk about a lot of psych. In fact, I'll probably make a full-up podcast to this because there's a lot of like high-yield stuff I really want to put out there with a psychiatry. So let's just jump right into it. So this is Rapid Review Series 20, if I'm not mistaken. Okay, so what if they give you a question about a patient that feels that he's the president of the United States and feels that, you know, I don't know, maybe like a famous person. He's his executive assistant and this person has only slept for like an hour every day for the past two weeks. And this person really doesn't have any need for food and they kind of feel like Superman. What's your diagnosis there? Well, I would hope you're saying that the person has a bipolar disorder. So bipolar disorder, literally the word bipolar means two pulls. Right, so that means those people are on twins of the spectrum. Right.

So they have like these manic episodes, right, which is typically characterized by the presence of dickfast symptoms. Right. So they have manic episodes characterized by dickfast symptoms. So like the structability, they're irritable. They have like these grandiose ideas. They have like these flight of ideas. They have like this rapid speech, the autocative and things of that nature. Right. They have a decreased need for sleep. Those are all things that go ahead with with a, with a mean. Right. So you know, they tend to have like mean. Yeah. And then they have to so that's one pull right and then the second pull that makes it by so to bipolar right to polar right. The second thing that makes up that is is a having a. I'm like a depressive episode. So whenever you see that think about bipolar disorder and the thing is you don't need to have both ends of the spectrum to make a diagnosis of bipolar disorder. If a person has manic episodes, that's more than fine. That more than cuts it for the diagnosis of a bipolar disorder. Right. And remember that those people need to have symptoms for at least more than a week. Okay. For you to see that you have bipolar disorder, but there's a weird exception to that room. The weird exception to that rule is if they have social dysfunction like significant social dysfunction or they need to be hospitalized, then all bets are off. One week rule does not apply anymore on that those circumstances, they still have bipolar disorder.

Now what is the drug of choice for treating bipolar disorder? When I would hope you're telling me lithium right remember lithium is the drug of choice for treating bipolar disorder. Remember that it is actually kind of high up to know for exams that lithium is one of two drugs in psychiatry that has been shown to decrease the risk of suicide. What is the other drug? I'll give you some hints. This other drug can cause like an edropenic fever. This drug can cause myocarditis so it can present as a dilithic cardiomyopathy on any of my exams. And this drug can also cause hyper salivation. What is the drug? Well, I would hope you're telling me a clasepin. Remember clasepin is an eti-picol anti-psychotic. Basically it's the most effective anti-psychotic of all. It's even more effective than a jaloparido. You may say a divine that's not true. I will encourage you to do your own research and look it up. Lithium, it decreases the risk of suicide is the drug of choice for bipolar disorder. Lithium is your friends at the MBM and they love to test it in the context of many of its unique side effects. One is hypothyroidism. Typically before you start a patient on a lithium, you try to get a baseline TSH to see where they're hanging out. And then that important thing with lithium is that lithium can also cause an effrogenic diabetes in sypedas. The MBM question, and obviously they will give you laps. And likely the person will have a high serum or a low urinose malarity.

This person is like 149. But their urinose malarity is like 200. If you see that, think about lithium with an effrogenic diabetes in sypedas. If you're going back to Rino from step one, remember that in the distone effron we have the principle cell. And that principle cell has an inech channel. If you go back to college chemistry, lithium is element 3 in the periodic table. And sodium is element 11 in the periodic table. So they're both in group one. So it's like if you're going with the valence or whatever, leave that to the people like children for the MCAT. But basically lithium is in group one. Sodium is in group one. So because they're both in group one, they have similar chemical properties. So because they have similar chemical properties and they actually have a fairly similar size. If sodium can use that inech channel at the level of the principle cell of the collecting duct, you bet that lithium can do the same thing. So lithium can do the same thing. So because lithium can do the same thing, you can get in through that inech channel and scrub the second messenger cascade of EDE tray. So that's the mechanism behind lithium causing an effrogenic diabetes in sypedas. So the thing is if you already know that lithium causes an effrogenic diabetes in sypedas well, and you know that it gains entry to that principle cell of the collecting duct through the inech channel.

Then it then stems to reason that you would want to ideally block that inech channel as a means of treating the inech genic diabetes in sypedas that is associated with lithium use. So those inech channel blockers, your key sparing diuretics like ameloride and triumtering, those are the drugs of choice for treating the inech genic diabetes in sypedas that is associated with lithium use. You'll try to trick you on the exam and give you like hydrochlorothiazyte because in general, when a person has an effrogenic diabetes in sypedas, hydrochlorothiazyte is actually the drug of choice for treating an effrogenic di, right? But the thing is there's an exception to that rule. And that rule is when a person has an effrogenic di from lithium use. When a person has an effrogenic di from lithium use, then you absolutely positively do not want to use a thiazide. If you use a thiazide, you will actually increase the person's risk of lithium toxicity, right? Because in general, anything that increases the activity of the renal angiotensin outosterone system who works in a person's lithium toxicity. So say for example, if a person is volume down, right? If you have volume down, your renal angiotensin outosterone system will be overrelated. You have more activity of outosterone. So that inech channel, remember our dostero. I mean, there is more stuff there, but again, this is a rapid review podcast. So I'm not going to go into a ton of extraneous detail.

I mean, it's not extraneous, especially for step one. But I think for step two, CK purposes, this should do. But basically, right? If you have volume down, the activity of your renal angiotensin outosterone system increases. And one of the things out dostero and dostero is that it increases the activity of that inech channel that you find that the principle cell of the collecting duct. So the thing that happens is when a person has his volume down, right? And that inech channel is working better. Yes, your reabsorb more sodium. But you also reabsorb an autonomous lithium. Because again, lithium uses that same inech channel to get back into the, get back into the nephra. So if a person takes HCTZ, HCTZ will drive you out to make your volume down because it's a diuretic. Now, I'll rev up your renal angiotensin outosterone system. And that is not awesome. If a person has lithium toxicity in the form of nephrogenic diabetes in sypedias. And hopefully you remember that the mechlocycline, remember that's a tetracycline. So it's like a bacterostatic 30s inhibitor. That's another drug that can also cause a nephrogenic diabetes in sypedias. In fact, we take advantage of that. For example, maybe you have like a patient on the exam that has like small cell lung cancer, right? And you have like SIDH as one of the panioplastic phenomena. One thing you can do is, I mean, obviously you do fluid restriction. Or you can give an EDH receptor antagonist, right?

So like your Kudivaptan or Tovaptan. But really another thing you can also consider doing is to give them the mechlocycline, which is a tetracycline, but it has nephrogenic diabetes in sypedias as a side effect. So you can take advantage of that in a treatine SIDH. Now, so I've talked about the hypothyroidism. That's associated with lithium use. I've talked about the nephrogenic diabetes in sypedias. That is associated with lithium use. Another thing you want to keep at the back of your mind with lithium is that it causes tremors. So lithium causes tremors. That's probably one of the most common side effects of lithium. And then another key thing you want to keep at the back of your mind with lithium is its teratogenicity. So lithium is a teratogenic. Lithium can cause Epstein's anomaly. So you essentially have like a downward displacement of the tricospit valve. So the boss phrase you want to recognize on exams is something known as the etralization of the right ventricle. So lithium can cause Epstein's anomaly under those circumstances. Although on NV Me exams, if you get a question about a lady that is on lithium, and she has bipolar disorder and it's been well controlled, right? And she gets pregnant. You don't really need to stop lithium. But if, for example, you discover a person has bipolar disorder impregnancy, now this is the drug of choice for bipolar disorder impregnancy is actually Hallopereodol.

Okay, Hallopereodol, or you can use any other kind of anti-psychotic. Now, one weird scenario I kind of want to introduce you to is because again, they've started doing this again on the new US Emily step 2 CK exam. Basically, if ever see me say the new US Emily step 2 CK exam, just imagine me, just essentially imagine the US Emily exam that essentially was introduced like three, four months ago. So the thing is, when a person has bipolar disorder, I just said that the drug of choice is lithium. That is absolutely true. But the thing is, if a person is acutely manic, you can give them lithium and hope for the best and wait for them to kind of like snap out of that manic state. So when a person is acutely manic, your drug of choice is actually an anti-psychotic. Okay, your drug of choice is actually an anti-psychotic. And then you start them on lithium at the same time to sort out like, get them, right, get them like therapeutic so that you can get them into chronic management of their bipolar disorder. And then another classic scenario you may see on NBM exam is, they may give you a question about a patient that has bipolar disorder, right? And then they tell you that, oh, the person has been on lithium doesn't appear to be controlling their symptoms appropriately. And then they ask for your next best step in management. One thing you can do is you can consume the lithium, but you also add on an anti-psychotic.

It's almost always an atypical anti-psychotic that you add on the NBM exam. So again, that's a very high yield thing to keep at the back of your mind for tests. And then lithium, I think that those are kind of like the big things I think I want to mention with lithium. I've talked about how it decreases the risk of suicide. Okay, now what if they give you a question? And essentially, I'm just going to do like a free for all because I want to do an head over somewhere quick. So if they give you a question about a patient and this patient has hypertension and they're taking some kind of psych drug, what drug are you thinking about? Well, I hope you're thinking about the SNR Is. Remember, the SNRI is like a vanilla vaccine, right? The vanilla vaccine, the SNRI is almost as a drug class, right? They tend to cause hypertension. And vanilla vaccine is the poster child one because I mean, yeah, there's other SNR Is, but they don't typically test those in the context of hypertension, right? So you know, the SNR Is like do lock the tin on my own assay plan, do lock the tin for the most part is used to treat like neuropathic pain. So especially like in people that have like a history of diabetes. And then my own assay plan is used to treat fibromyalgia on NBM exams. Okay, but if you see hypertension, psych med, think about vanilla fax. And then what if they give you a question about a patient that is now having low libido and they recently studied a psych med, right?

I would hope on that those circumstances, you're thinking about things like your SSR Is and your SNR Is, right? So remember your SSR Is and things like fluoxetine, sexualin, citaluperam, isitaluperam, fluvoxamine. Those are your big time SSR Is, right? And again, remember, your SSR Is, the classic side effects, sexual dysfunction like low libido. Although you can actually take advantage of that. But essentially, if a person has like a premature ejaculation, right? So let's say, you know, a guy gets too excited, you know, he gets excited like pretty quickly. So it's like, oh, once he starts within like three minutes, he's willing to, you know, release that stuff, right? So if a person has premature ejaculation, the drug of choice in that situation is actually, is actually an SSRI. Because we essentially take advantage of the sexual dysfunction to kind of restrain the person as sexually, right? So that's the drug of choice for treating a premature ejaculation. And then remember that your SSR Is, they can also cause them with gain, right? Your SSR Is can cause with gain, they can cause sexual dysfunction. And remember that you can actually use them on NV Me exams to treat a PMDD, right? So like premenstrual dysphoric disorder. Essentially, the way PMDD presents on NV Me exams, they'll talk about a woman that around the time of her men's teeth, she just has like just terrible symptoms, like really bad like depression.

Yeah, yeah, yeah, yeah, yeah, if you see that, think about a PMDD premenstrual dysphoric disorder, the drugs of choice for treating those are your SSR Is. So again, that's something I hope to know for exams. And then remember your SSR Is are also the drugs of choice for treating generalized anxiety disorder, right? Although for GAD, a second line medication, we consider using this boost mirror, right? Bospiro, remember, boost mirror is a partial agonist at serotonin 5-HT2 A receptors, okay? So that's something when you keep at the back of your mind for tests. And remember that generalized anxiety disorder, you need to have symptoms for six months for you to see that a person has generalized anxiety disorder, right? And your SSR Is are also used to treat major depressive disorder, right? And again, major depressive disorder, remember your CIGI cap symptoms, right? For more than two weeks, right? You need to have five out of nine of those CIGI cap symptoms, right? So what does CIGI cap stand for? Right? So the S is for sleep, right? The S is for loss of interest, the G is for guilt, the E is for low energy, the C is for poor concentration, the A is for issues with appetite, the P is for like psychomonal retardition, the S is for suicidal ideation. So you may see, if I just said five out of nine, right? And CIGI cap is an eight letter word, well, the other thing is a loom, loom is nine, okay? So you need five out of nine CIGI cap symptoms for two weeks or more, okay?

For two weeks or more. If you get an NV Me exam question and a person seems to have like many of the symptoms of MGG, but they don't have up to five out of nine of those CIGI cap symptoms or they have like the five or more out of nine, but they don't meet the time frame, right?

And then they tell you that the person had like a recent risk or like family member was recently diagnosed with a bad disease or the person recently broke up with your girlfriend, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah Yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah,

yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, y

eah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, ye

ah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah

yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah

yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah, yeah I'm going to extend it to even 20 hours for you, right?

You can always let me know, again, my eye, I can, I have done, I mean, I feel like 10 hours is good, right? But there's some people have done these courses with that is run like 20 hours, 25 hours, if they wanted to be like all like super, super like that's probably going on to the room of like something like relatively more comprehensive than a 10 hour course, okay? So if you're interested in any of that, feel free to reach out to me. So I wish you a wonderful rest of your day. I'll see you in the next podcast. God bless you. Thank you.

Practice questions — USMLE style

Question 1 — Nephrology/Psychopharmacology

A 45-year-old woman with a history of bipolar disorder is stable on lithium therapy but presents with polyuria and polydipsia, suggestive of nephrogenic diabetes insipidus (NDI). She has been experiencing symptoms that are refractory to standard treatment. Which of the following agents should be avoided in this patient due to increased risk of lithium toxicity?

A) Amiloride
B) Tolvaptan
C) Hydrochlorothiazide
D) Fluvoxamine

Answer: C. The transcript emphasizes that while hydrochlorothiazide (HCTZ) is generally the drug of choice for treating NDI, it must be avoided in a patient with lithium-induced NDI. Thiazides increase the activity of the renal angiotensin-aldosterone system (RAAS), which increases sodium reabsorption and subsequently enhances the reabsorption of lithium via the same nephron channel, leading to increased risk of lithium toxicity. Amiloride and Tolvaptan are appropriate alternatives or treatments for this condition.

Question 2 — Psychiatry/Endocrinology

A 30-year-old man is admitted to the emergency department during an acute manic episode. He exhibits grandiosity, rapid speech (flight of ideas), decreased need for sleep, and irritability. His primary care physician suspects bipolar disorder. Given his acutely manic state, what combination of agents represents the most appropriate initial management strategy?

A) Lithium monotherapy alone
B) Valproic acid followed by fluoxetine
C) An antipsychotic agent combined with lithium
D) Carbamazepine monotherapy

Answer: C. The transcript notes that while lithium is the drug of choice for maintenance treatment of bipolar disorder, an acutely manic patient requires immediate stabilization. Therefore, the initial management should involve an anti-psychotic agent (to control acute symptoms) alongside starting lithium to begin long-term therapeutic management. Lithium monotherapy alone may not be sufficient for acute mania, and while valproic acid or carbamazepine are alternatives, combining an antipsychotic with lithium is a standard high-yield approach taught in this context.

Question 3 — Psychiatry/Pharmacology

A 28-year-old male presents to the clinic reporting chronic low libido and occasional premature ejaculation (PE). He has been taking various psychotropic medications for generalized anxiety disorder, including an SSRI. Which class of medication is most likely responsible for his sexual side effects, and what drug mechanism could be utilized therapeutically to treat his PE?

A) SNR Is; using the agent's effect on norepinephrine reuptake
B) TC As; administering a low dose to block presynaptic release
C) SSR Is; leveraging the inhibition of serotonin reuptake
D) Benzodiazepines; increasing GAB Aergic tone

Answer: C. The transcript highlights that SSR Is are classic causes of sexual dysfunction, including low libido. Crucially, it also states that because SSR Is inhibit serotonin reuptake, this side effect can be leveraged therapeutically to treat premature ejaculation (PE), as the mechanism slows down orgasm. This makes SSR Is the most relevant drug class and mechanism for both the cause and the treatment of PE in this context.

Question 4 — Psychiatry/Pharmacology

A patient with small cell lung cancer is diagnosed with syndrome of inappropriate antidiuretic hormone secretion (SIADH). The physician considers using a tetracycline antibiotic, methoclopramide, as an alternative agent to manage the SIADH due to its known side effect profile. What mechanism explains why this drug could be used in this specific therapeutic manner?

A) Methoclopramide blocks ADH receptors, preventing water reabsorption.
B) Methoclopramide causes nephrogenic diabetes insipidus (NDI), which can counteract the effects of SIADH.
C) Methoclopramide increases aldosterone activity, promoting sodium excretion.
D) Methoclopramide is a competitive inhibitor of vasopressin synthesis in the hypothalamus.

Answer: B. The transcript specifically mentions that methoclopramide (a tetracycline) can cause nephrogenic diabetes insipidus (NDI). Since SIADH involves excessive water retention due to ADH excess, administering an agent that causes NDI effectively counteracts the symptoms of SIADH by promoting free water excretion. This is a classic example of using a drug's side effect therapeutically.

Quick fire review

What is the primary anti-suicidal property associated with lithium?

Lithium has been shown to decrease the risk of suicide in bipolar disorder patients.

If a patient on lithium develops NDI and volume depletion occurs, what mechanism exacerbates the problem?

Volume depletion increases the activity of the Renin-Angiotensin-Aldosterone System (RAAS), which enhances E NaC channel activity, increasing lithium reabsorption.

What is the key side effect associated with lithium that requires baseline monitoring before starting therapy?

Hypothyroidism; therefore, a baseline TSH level should be checked.

Which drug class of antidepressants is classically associated with causing hypertension?

SNR Is (Serotonin-Norepinephrine Reuptake Inhibitors), especially venlafaxine.

What specific anti-psychotic agent is recommended as the first-line choice for bipolar disorder during pregnancy?

Haloperidol (or other antipsychotics, though haloperidol was mentioned in context). Correction based on transcript: The drug of choice for bipolar disorder during pregnancy is actually Haloperidol.

What symptom constellation requires 5 out of 9 symptoms for at least two weeks to meet criteria for Major Depressive Disorder?

CIGICAPS (Sleep, Loss of interest, Guilt, Low energy, Poor concentration, Appetite issues, Psychomotor retardation, Suicidal ideation).

What is the mechanism by which lithium causes Nephrogenic Diabetes Insipidus (NDI)?

Lithium enters the principal cell of the collecting duct via the E NaC channel. High RAAS activity (e.g., volume depletion) increases E NaC activity, leading to increased lithium reabsorption and subsequent NDI.

What are two key sparing diuretics used to treat lithium-induced NDI?

Amiloride or Triamterene (these block the E NaC channel).

What is the specific teratogenic anomaly associated with lithium exposure in utero?

Epstein's anomaly, characterized by downward displacement of the tricuspid valve.

If a patient has bipolar disorder and is acutely manic, what drug class should be used for immediate stabilization while initiating chronic care?

An anti-psychotic agent (e.g., atypical antipsychotics).

What specific symptom constellation must persist for 6 months to diagnose Generalized Anxiety Disorder (GAD)?

Excessive anxiety and worry about multiple events/activities, occurring more days than not over a period of at least six months.

Which SSRI class is the drug of choice for treating premature ejaculation?

SSR Is (Selective Serotonin Reuptake Inhibitors), because their side effect profile can be leveraged to delay orgasm.

Quick recall / Anki-style questions